Phase 1 clinical trial of losmapimod in facioscapulohumeral dystrophy: Safety, tolerability, pharmacokinetics, and target engagement - Mellion, M L; Ronco, L; Berends, C L (Br J Clin Pharmacol, 2021)
et al.